AzTrials
AzTrials

Dental Pulp NecrosisMIXCRYONCT05739682

Pain and Microbial Reduction of Antimicrobial Corticosteroid Mixture Versus Cryotherapy in Necrotic Teeth

A study testing Local anaesthetic injection of 4% articaine with 1:100000 epinephrine, Tooth isolation and Access cavity preparation in people with Dental Pulp Necrosis, run by Cairo University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this study is to compare the effect of antimicrobial-corticosteroid mixture and cryotherapy as final root canal irrigating solutions on post-instrumentation pain in single-canal teeth with necrotic pulps. Read more about this study

Who is it for?
Ages 18 to 50 years
Conditions the study is for
Dental Pulp Necrosis
What is being tested?
Local anaesthetic injection of 4% articaine with 1:100000 epinephrine, Tooth isolation and Access cavity preparation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
28 participants
Where
1 siteEgypt
Study dates
1 Jul 2024to 9 Feb 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 50 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Patients in good physical health; American Society of Anesthesiologists class I or II.
  • Patients whose age ranges between 18 and 50 years.
  • Male and female patients.
  • Patients having a single canal-tooth with necrotic pulp.
  • Patients who can understand the number rating scale (figure).
  • Patients who accept to participate in the trial and can sign the informed consent (figure).

Who cannot join

  • Pregnant females.
  • Patients with swelling.
  • Patients whose tooth is non-restorable.
  • Teeth with open apices.
  • Teeth with radiographic evidence of root resorption.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Faculty of Dentistry, Cairo University

    Cairo, Manial, 12613

Other trials in Egypt

About this study

Official title: The Effect of Final Irrigation Using Antimicrobial-corticosteroid Mixture Versus Cryotherapy on Post-instrumentation Pain and Microbial Reduction in Patients Having Single Canal - Teeth With Necrotic Pulps: A Randomized Clinical Trial

The aim of this study is to compare the effect of antimicrobial-corticosteroid mixture and cryotherapy as final root canal irrigating solutions on post-instrumentation pain in single-canal teeth with necrotic pulps.

Read the detailed description

The trial participants are patients with single-canal teeth with necrotic pulps undergoing root canal treatment on two visits. During the 1st visit, access cavity, root canal cleaning and shaping using rotary files and 2.5% NaOCl irrigation. After apical preparation, a final flush with either a levofloxacin-fluconazole-dexamethasone mixture or cold saline will be used then the tooth access cavity will be sealed with a temporary filling. After the first visit, the participants will be given a pain chart with a numerical rating scale to rate their pain levels from zero to 10 at 6, 12, 24, and 48 hours. Three microbial swabs will be collected for each participant: before instrumentation (S1), after instrumentation before final irrigation (S2), and after final irrigation (S3). After collecting data from all participants, statistical analysis will be conducted to compare the pain intensity and microbial load reduction percentages between the two groups.

Being tested
Local anaesthetic injection of 4% articaine with 1:100000 epinephrine, Tooth isolation, Access cavity preparation, Root canal shaping and cleaning, Final irrigation with antimicrobial-corticosteroid mixture
Keywords
Antibiotic, Antifungal, Corticosteroid, Cryotherapy
Medical subject headings
Dental Pulp Necrosis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Local anaesthetic injection of 4% articaine with 1:100000 epinephrineProcedure or surgery

    Buccal infiltration injection using a side loading aspirating syringe and a 30-gauge needle

  • Tooth isolationProcedure or surgery

    Rubber dam application to the affected tooth

  • Access cavity preparationProcedure or surgery

    Complete removal of caries, undermined tooth structure, and defective restoration. Access cavity preparation with complete removal of the pulp chamber roof using a sterile bur other than the ones used for caries removal.

  • Root canal shaping and cleaningProcedure or surgery

    Working length determination using an electronic apex locator and then canal instrumentation using Hyflex CM rotary files up to size 40.04 with irrigation using 2.5% NaOCl between files.

  • Final irrigation with antimicrobial-corticosteroid mixtureProcedure or surgery

    1 ml of levofloxacin will be withdrawn in a 3ml plastic syringe followed by 1 ml of fluconazole and 1 ml of dexamethasone sodium phosphate, the whole solution is then passively delivered into the canal using a 30-gauge side vented needle reaching 1 mm shorter than the working length. The solution will be left inside the canal for 5 minutes

  • Final irrigation with cold salineProcedure or surgery

    Frozen sterile saline will be brought at room temperature and monitored using a digital liquid thermometer till the temperature reaches 2.5°c. 4ml are then withdrawn in a 5ml plastic syringe and delivered inside the canal in 1 minute. The process is then repeated 5 times so that the canal receives 20 ml of 2.5°c cold saline for 5 minutes.

  • Temporary restoration and patient's instructionsProcedure or surgery

    The canals are dried using paper points and the access cavity is sealed using a non-eugenol temporary filling.

  • Root canal obturationProcedure or surgery

    After the 1st visit by 3 days to 1 week, the patient is scheduled for a second appointment for root canal obturation.

Study groups in NCT05739682
Study groupRoleWhat they receive
Antimicrobial Corticosteroid mixtureExperimentalEach canal will receive 5 minutes of final irrigation with the antimicrobial-corticosteroid solution of a freshly prepared mixture of: 1 ml of Levofloxacin (Tavanic, Sanofi Aventis, Egypt). 1 ml of Fluconazole (Sunny fungal, Sunny pharmaceuticals, Egypt). 1 ml of Dexamethasone sodium phosphate (Dexamethasone, Amriya, Egypt).
Receives: Procedure: Local anaesthetic injection of 4% articaine with 1:100000 epinephrine; Procedure: Tooth isolation; Procedure: Access cavity preparation; Procedure: Root canal shaping and cleaning; Procedure: Final irrigation with antimicrobial-corticosteroid mixture; Procedure: Temporary restoration and patient's instructions; Procedure: Root canal obturation
CryotherapyActive comparatorEach canal will receive final irrigation with 20ml of cold saline (2.5°c) for 5 minutes.
Receives: Procedure: Local anaesthetic injection of 4% articaine with 1:100000 epinephrine; Procedure: Tooth isolation; Procedure: Access cavity preparation; Procedure: Root canal shaping and cleaning; Procedure: Final irrigation with cold saline; Procedure: Temporary restoration and patient's instructions; Procedure: Root canal obturation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Postinstrumentation pain

    Pain as reported by the patient on a Numerical rating scale from 0 to 10 where 0 indicates no pain and 10 indicates the worst possible pain

    Measured: At 6 hours after the 1st visit

  2. Postinstrumentation pain

    Pain as reported by the patient on a Numerical rating scale from 0 to 10 where 0 indicates no pain and 10 indicates the worst possible pain

    Measured: At 12 hours after the 1st visit

  3. Postinstrumentation pain

    Pain as reported by the patient on a Numerical rating scale from 0 to 10 where 0 indicates no pain and 10 indicates the worst possible pain

    Measured: At 24 hours after the 1st visit

  4. Postinstrumentation pain

    Pain as reported by the patient on a Numerical rating scale from 0 to 10 where 0 indicates no pain and 10 indicates the worst possible pain

    Measured: At 48 hours after the 1st visit

Secondary outcomes (2)
  1. Anti bacterial effect

    percentage of bacterial reduction after final irrigation as compared to after instrumentation.

    Cultures from collected paper points will be inoculated in sterile brain heart infusion (BHI) broth vials which will be dispersed with vortex for 30 seconds. The sterile BHI broth solution will then be serially diluted one-tenth dilution and plated onto the blood agar medium and incubated at 37°C aerobically for 24 hours. The resultant bacterial growth will be quantified by evaluating the number of colonies on the agar medium \& the number of CFU/ml of each dilution will be calculated for each sample.

    Measured: At 24 hours after the 1st visit

  2. Antifungal effect

    Percentage of Candidal reduction after final irrigation as compared to after instrumentation.

    Cultures from collected paper points will be inoculated in sterile brain heart infusion (BHI) broth vials which will be dispersed with vortex for 30 seconds. The sterile BHI broth solution will be serially diluted one-tenth dilution and plated onto Sabouraud dextrose agar medium and incubated at 25°C aerobically for 48 hours. The resultant candida growth will be quantified by evaluating the number of colonies on the agar medium \& the number of CFU/ml of each dilution will be calculated for each sample.

    Measured: At 48 hours after the 1st visit

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Feb 2023
  2. Study start1 Jul 2024
  3. Primary completion30 Jan 2025
  4. Study completion9 Feb 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
28 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05739682
Sponsor's protocol ID
ENDO 18-11-21
Acronym
MIXCRYO
Status last verified
Feb 2025
First submitted
18 Nov 2021
Last updated
5 Jun 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: We are planning to share individual patient's data regarding age, gender, preoperative pain score and outcome data

Questions about this trial

What is this clinical trial studying?

A study testing Local anaesthetic injection of 4% articaine with 1:100000 epinephrine, Tooth isolation and Access cavity preparation in people with Dental Pulp Necrosis, run by Cairo University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 5 Jun 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Postinstrumentation pain (time frame: At 6 hours after the 1st visit). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Jun 2025; AzTrials last refreshed its copy on 8 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in